Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microbial conversion of ansamitocin

K Nakahama, M Izawa, M Asai

    The Journal of Antibiotics
    |December 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    On the adsorption and reactivity of element 114, flerovium.

    Frontiers in chemistry·2022
    Same author

    Multifaceted array-based keloidal gene expression profiling reveals specific MDFI upregulation in keloid lesions.

    Clinical and experimental dermatology·2021
    Same author

    Study of charged particle activation analysis (II): Determination of boron concentration in human blood samples.

    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2020
    Same author

    Preliminary results in using Deep Learning to emulate BLOB, a nuclear interaction model.

    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2020
    Same author

    Preliminary results coupling "Stochastic Mean Field" and "Boltzmann-Langevin One Body" models with Geant4.

    Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2019
    Same author

    Loss of hypothalamic corticotropin-releasing hormone markedly reduces anxiety behaviors in mice.

    Molecular psychiatry·2016

    Microbial screening identified actinomycetes capable of modifying ansamitocin structures. These microorganisms converted ansamitocin P-3 into novel antitumor compounds, expanding potential therapeutic applications.

    Area of Science:

    • Microbiology
    • Natural Product Chemistry
    • Biotechnology

    Background:

    • Ansamitocins are a class of ansamycin antibiotics with antitumor properties.
    • Microbial biotransformation offers a pathway to generate novel drug derivatives.
    • Exploring microbial capabilities for ansamycin modification is crucial for drug discovery.

    Purpose of the Study:

    • To screen various microorganisms for their ability to structurally modify ansamitocins.
    • To identify specific microbial strains and their enzymatic activities in ansamycin biotransformation.
    • To characterize the resulting ansamycin derivatives produced by microbial conversion.

    Main Methods:

    • Screening of bacteria, actinomycetes, yeasts, and fungi for ansamitocin modification.
    • Cultivation of selected microbial strains, including Bacillus megaterium, Streptomyces coelicolor, and others.

    Related Experiment Videos

  • Isolation and structural identification of microbial conversion products using analytical techniques.

    • Main Results:

    • Multiple microbial strains, predominantly actinomycetes, demonstrated the ability to convert ansamitocin P-3.
    • Four key products (compounds A, B, C, and D) were identified as 20-O-demethylansamitocin P-3, maytansinol, 15-hydroxyansamitocin P-3, and N-demethylansamitocin P-3.
    • Other maytansinoids also underwent similar microbial transformations, indicating broad substrate potential.

    Conclusions:

    • Microbial biotransformation is an effective strategy for generating novel ansamitocin derivatives.
    • Specific actinomycete strains possess enzymes capable of significant structural modifications of ansamitocins.
    • This study provides a foundation for developing new antitumor agents through microbial engineering.